MWP
AXDX

MYCIO Wealth Partners’s Accelerate Diagnostics AXDX Stock Holding History

MYCIO Wealth Partners’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5
Closed -$1K – 253
2016
Q3 		$1K Buy
+5
New +$1.11K ﹤0.01% 797

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

MYCIO Wealth Partners's AXDX Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Accelerate Diagnostics (AXDX) in Q4 2016, closing a stake of 5 shares — an estimated $1K sold.

MYCIO Wealth Partners first reported a position in AXDX in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2016.

  • MYCIO Wealth Partners reported no remaining Accelerate Diagnostics position as of Q4 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 5 Accelerate Diagnostics shares in Q4 2016, an estimated $1K.
  • MYCIO Wealth Partners first reported a position in Accelerate Diagnostics in Q3 2016 and held it in 1 quarter.
  • MYCIO Wealth Partners's Accelerate Diagnostics position peaked at $1K in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.